Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -96.37% is in line with its 5-year average of -88.63%, around the middle of its 5-year range (-211.89%–-22.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 46.28% above its 12-month average of -179.41%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -96.37%.
RETURN ON INVESTED CAPITAL (ROIC)
-96.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-179.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-122.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-88.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+46.28%
CURRENT VS 3Y AVG
+21.55%
CURRENT VS 5Y AVG
-8.74%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.80%
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-185.13%
vs the sector median at left
INmune Bio, Inc.
Market Cap
$50.80M
Return on Invested Capital (ROIC)
-96.37%
TTM Avg
-179.41%
3Y Avg
-122.85%
5Y Avg
-88.63%
Market Cap
$51.56M
Return on Invested Capital (ROIC)
-109.13%
TTM Avg
-196.06%
3Y Avg
-152.48%
5Y Avg
-122.21%
Market Cap
$50.96M
Return on Invested Capital (ROIC)
-208.76%
TTM Avg
-1171.68%
3Y Avg
-1173.13%
5Y Avg
-939.08%
Market Cap
$51.36M
Return on Invested Capital (ROIC)
-63.96%
TTM Avg
-125.67%
3Y Avg
-108.34%
5Y Avg
-82.96%
Market Cap
$51.42M
Return on Invested Capital (ROIC)
-157.40%
TTM Avg
-135.65%
3Y Avg
-123.35%
5Y Avg
-111.97%
Market Cap
$50.36M
Return on Invested Capital (ROIC)
-26.51%
TTM Avg
-172.21%
3Y Avg
-183.20%
5Y Avg
-141.01%
Market Cap
$51.70M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-690.86%
3Y Avg
-402.79%
5Y Avg
-302.68%
Market Cap
$52.05M
Return on Invested Capital (ROIC)
13.63%
TTM Avg
32.98%
3Y Avg
9.79%
5Y Avg
24.14%
Market Cap
$49.93M
Return on Invested Capital (ROIC)
-192.99%
TTM Avg
-98.03%
3Y Avg
-92.21%
5Y Avg
-72.34%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INmune Bio, Inc. (INMB) | $50.80M | -96.37% | -179.41% | -122.85% | -88.63% |
| Clene Inc. (CLNN)vs › | $51.56M | -109.13% | -196.06% | -152.48% | -122.21% |
| Envoy Medical, Inc. (COCH)vs › | $50.96M | -208.76% | -1171.68% | -1173.13% | -939.08% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.36M | -63.96% | -125.67% | -108.34% | -82.96% |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | -157.40% | -135.65% | -123.35% | -111.97% |
| Microbot Medical Inc. (MBOT)vs › | $50.36M | -26.51% | -172.21% | -183.20% | -141.01% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.70M | N/A | -690.86% | -402.79% | -302.68% |
| biote Corp. (BTMD)vs › | $52.05M | 13.63% | 32.98% | 9.79% | 24.14% |
| Celularity Inc. (CELU)vs › | $49.93M | -192.99% | -98.03% | -92.21% | -72.34% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | -38.04% | -22.77% | -89.18% | -83.00% |
ROIC
-96.4%
ROE
-90.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -96.37% |
| 2026-03-31 | -211.89% |
| 2025-12-31 | -197.97% |
| 2025-09-30 | -197.59% |
| 2025-06-30 | -193.24% |
| 2025-03-31 | -138.99% |
| 2024-12-31 | -131.83% |
| 2024-09-30 | -100.23% |
| 2024-06-30 | -89.16% |
| 2024-03-31 | -93.21% |
| 2023-12-31 | -61.38% |
| 2023-09-30 | -46.29% |
| 2023-06-30 | -38.88% |
| 2023-03-31 | -36.37% |
| 2022-12-31 | -34.20% |
| 2022-09-30 | -36.95% |
| 2022-06-30 | -36.15% |
| 2022-03-31 | -34.11% |
| 2021-12-31 | -30.50% |
| 2021-09-30 | -22.68% |
| 2021-06-30 | -33.15% |
| 2021-03-31 | -23.06% |
| 2020-12-31 | -31.45% |
| 2020-09-30 | -27.46% |
| 2020-06-30 | -44.05% |
| 2020-03-31 | -35.18% |
| 2019-12-31 | -32.63% |
| 2019-09-30 | -29.35% |
| 2019-06-30 | -21.32% |
| 2019-03-31 | -50.32% |
| 2018-12-31 | -75.21% |
| 2018-09-30 | -62.91% |
| 2018-06-30 | -54.10% |
| 2018-03-31 | -20.11% |
| 2017-12-31 | -5.64% |
| 2017-09-30 | -35.22% |
